Home
Investors
Sientra.com
Overview
News
Events
Financial Info
Quarterly Reports
SEC Filings
Stock Info
Quote & Chart
Analyst Coverage
Governance
Documents & Charters
Management
Board of Directors
Committee Composition
Resources
FAQs
E-mail Alerts
RSS Feeds
contact IR
News
Elieen, Actual Sientra Patient
Normal
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 29, 2022
Sientra Expands Global Footprint With Regulatory Approval to Market Breast Implants in the United Arab Emirates
December 13, 2022
Sientra Announces Launch Of Viality™, A Novel Fat Transfer System
December 5, 2022
Sientra Reports Record Third Quarter 2022 Financial Results
November 10, 2022
Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022
October 31, 2022
Sientra Announces Pricing of $13.2 Million Public Offering
October 21, 2022
Sientra Announces Proposed Public Offering
October 18, 2022
Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management
October 12, 2022
Sientra Supports Breast Cancer Awareness Month by Launching Educational Programs Designed to Empower Women
October 3, 2022
Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia
September 20, 2022
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 6, 2022
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
August 11, 2022
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022
Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation
July 11, 2022
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
July 6, 2022
Sientra To Present At The William Blair 42nd Annual Growth Stock Conference
May 23, 2022
Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference
May 18, 2022
Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022
May 12, 2022
Sientra to Report First Quarter 2022 Financial Results on May 12, 2022
May 3, 2022
Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
March 24, 2022
Sientra Receives Regulatory Approval to Market Breast Implants in Canada
March 24, 2022
Sientra Reports Record Plastic Surgery Revenue for Both Fourth Quarter and Full Year 2021
March 23, 2022
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
March 10, 2022
Sientra to Report Fourth Quarter and Full Year 2021 Financial Results on March 23, 2022
March 9, 2022
Sientra Reports Record Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenues
January 10, 2022
Sientra Announces Acquisition of Novel Fat Grafting Technology from AuraGen Aesthetics, LLC
January 5, 2022
Nasdaq: SIEN
Stock Quote:
NASD
$
2.78
+
0.18
Volume
79,336
Previous Close
2.60
Intraday High
2.84
Intraday Low
2.60
Pricing delayed 20 minutes
Price
Change
% Change
+
6.92%
52 Week High
8.88
52 Week Low
1.25
Today's Open
2.65
Sep 29, 2023 04:00 PM
Email Alerts
Email:
*
Subscription Preferences
*
Press Release
SEC Filing
Event
EOD Stock Quote
Enter the code shown above.
Investor Contact
Sientra Investor Relations
ir@sientra.com
Privacy Statement
|
Terms of use
|
Safety
|
Compliance
|
Resources
|
Patents
|
Contact Us
|
Careers
© 2021 Sientra, Inc. All rights reserved.